Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 known ✓ | Q01959 | 11/20 | 0.59 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.59 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.49 |
| ▸ | CHRNG | P07510 | 1/20 | 0.49 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.49 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.49 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.49 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.49 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.49 |
| ▸ | CHRND | Q07001 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL3553053 | 1.00 | SLC6A3 (0.59) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| Cadaverine Tartrate SCHEMBL2639730 | 1.00 | SLC6A3 (0.59) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| Cadaverine Tartrate SCHEMBL2639906 | 0.99 | SLC6A3 (0.58) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL13227345 | 0.89 | SLC6A3 (0.61) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL4433623 | 0.89 | SLC6A3 (0.61) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL2640060 | 0.89 | SLC6A3 (0.61) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL3587139 | 0.89 | SLC6A3 (0.61) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL12313096 | 0.89 | SLC6A3 (0.61) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| Citric Acid SCHEMBL3540863 | 0.85 | SLC6A3 (0.55) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG | |
| SCHEMBL13255979 | 0.81 | SLC6A3 (0.62) | SLC6A3SLC6A4SLC6A2CHRNA1CHRNG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651223-A1 | 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8-AZABICYCLO[3.2.1]OCTANE TARTRATE SALTS | NEUROSEARCH A/S (DK) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005011694-A1 | 2-METHOXYMETHYL-3-(3,4-DICHLOROPHENYL)-8-AZABICYCLO[3.2.1]OCTANE TARTRATE SALTS | NEUROSEARCH A/S (DK) | 2005-02-10 | — | — | WO | disclosed |